Literature DB >> 11204987

Colon polyps and cancer.

J H Bond1.   

Abstract

During 1999-2000, a number of important issues related to endoscopy and colorectal polyps and cancer were investigated. Several papers consider whether flat adenomas with high malignant potential are as common in the West as in Japan. Clinical series indicate that signs of rectal bleeding are more predictive of colorectal cancer than gastrointestinal symptoms. Colonoscopy is more accurate than double-contrast barium enema for detecting polyps, and virtual colonoscopy is a promising new diagnostic and screening technique. Primary prevention dietary studies using adenoma recurrence as an end point yield negative results. Surveillance colonoscopy protects individuals in families with hereditary nonpolyposis colorectal cancer, but gastroenterologists continue to perform cancer surveillance in patients with ulcerative colitis in an inconsistent manner. Screening for colorectal neoplasia with fecal occult blood tests and flexible sigmoidoscopy is being better defined and promoted, although many now advocate direct colonoscopy screening based on increasing indirect evidence of efficacy. Better methods of treating large sessile neoplasms are being developed and evaluated, and follow-up surveillance for adenoma patients increasingly is being tailored to individual patient risk.

Entities:  

Mesh:

Year:  2001        PMID: 11204987     DOI: 10.1055/s-2001-11185

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  2 in total

1.  [Colorectal cancer in Germany. Means for prevention and early detection: implications for laiety and physicians].

Authors:  A Eickhoff; C Maar; B Birkner; J F Riemann
Journal:  Internist (Berl)       Date:  2003-03       Impact factor: 0.743

2.  Gasless, video endoscopic transanal excision for carcinoid and laterally spreading tumors of the rectum.

Authors:  T Nakagoe; H Ishikawa; T Sawai; T Tsuji; M Jibiki; A Nanashima; H Yamaguchi; T Yasutake
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.